Recombinant Porcine transmissible gastroenteritis coronavirus Envelope small membrane protein (E)

Shipped with Ice Packs
In Stock

Description

Production and Characterization

The recombinant E protein is typically expressed in E. coli, with a His tag added for affinity chromatography. Key production parameters include:

ParameterSpecificationSource
Host SystemE. coli
Purity>90% (SDS-PAGE)
Storage BufferTris/PBS-based buffer, 6% trehalose, pH 8.0
ReconstitutionDeionized sterile water (0.1–1.0 mg/mL) with 5–50% glycerol

The protein is lyophilized and stored at -20°C/-80°C to maintain stability .

Functional Role in Coronavirus Biology

The E protein plays dual roles in viral replication and immune modulation:

Role in Virion Assembly and Release

  • Ion Channel Activity: Forms viroporins that facilitate ion transport across membranes, aiding viral release .

  • Membrane Curvature: Interacts with the M protein to induce membrane budding and virion morphogenesis .

  • Virus-Like Particle (VLP) Formation: Coexpression with M protein enables VLP assembly in vitro .

Immune Evasion and Inflammation

  • Interferon Induction: Recombinant E/M protein complexes trigger IFN-α production in porcine peripheral blood mononuclear cells .

  • Receptor Interactions: Not directly involved in host receptor binding (unlike the spike S protein) but influences viral tropism indirectly .

Genetic and Functional Studies

  1. Transmembrane Domain Mutagenesis:

    • Disruption of the hydrophobic domain via alanine scanning reduces virus yields and plaque size .

    • Polar residues (e.g., Thr, Asn) in the transmembrane helix are critical for ion channel function and virion assembly .

  2. VLP Assembly Dependency:

    • E protein is indispensable for VLP formation; mutations in M protein (e.g., E121A) abrogate E-mediated VLP production .

    • N protein coexpression enhances VLP yields by ~25–45% .

Comparative Pathogenicity

VirusE Protein DependencyOutcomeSource
TGEVEssential for replication; deletion blocks virus productionNo viable virions
MHVNon-essential; viable mutants with reduced titersAttenuated replication
SARS-CoVImportant but not strictly required; yields drop 20–200-foldPartial replication

Vaccine and Therapeutic Development

  • Recombinant Virus Vectors: TGEV-based vectors expressing heterologous antigens (e.g., rotavirus VP7) leverage E protein for immunogenicity .

  • Antiviral Target: Ion channel inhibitors (e.g., hexamethylene amiloride) block E-mediated viral release, offering therapeutic potential .

Challenges and Limitations

  • Post-Translational Modifications: E. coli-derived E lacks glycosylation, which may affect native-like functionality .

  • Stability: Repeated freeze-thaw cycles degrade protein integrity, necessitating strict storage protocols .

  • Species-Specific Differences: Structural and functional divergence between porcine and human coronavirus E proteins complicates cross-species studies .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on purchasing method and location. Contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our default glycerol concentration is 50% and serves as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid forms have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If a specific tag type is required, please inform us for prioritized development.
Synonyms
E; sM; 4; Envelope small membrane protein; E protein; sM protein
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-81
Protein Length
full length protein
Species
Porcine transmissible gastroenteritis coronavirus (strain FS772/70) (TGEV)
Target Names
E
Target Protein Sequence
MTFPRALTVIDDNGLVISIIFWFLLIIILILFSIALLNIIKLCMVCCNLGRTVIVPVQHA YDAYKNFMRIKAYNHDGALLV
Uniprot No.

Target Background

Function

This protein plays a crucial role in transmissible gastroenteritis coronavirus (TGEV) morphogenesis and assembly. It functions as a viroporin, self-assembling into pentameric protein-lipid pores within host membranes. These pores facilitate ion transport. Furthermore, this protein contributes to the induction of apoptosis.

Protein Families
Alphacoronaviruses E protein family
Subcellular Location
Host Golgi apparatus membrane; Single-pass type III membrane protein.

Q&A

What is the basic structure and topology of TGEV envelope protein?

TGEV ORF4 encodes a small membrane protein of approximately 82 amino acids that serves as a minor structural component of the virion. Research confirms it is a membrane-associated protein with a predicted membrane-spanning segment. The protein adopts a Cexo-Nendo orientation (C-terminus external, N-terminus internal) within the membrane. Immunoprecipitation studies with monoclonal antibodies have confirmed that approximately 20 molecules of this protein are incorporated per virus particle . The protein's C-terminal domain contains important targeting information, with studies on the related IBV E protein revealing that the Golgi-targeting information is primarily located between amino acid residues 44 and 72 .

How does the TGEV E protein contribute to viral pathogenesis?

The E protein functions as an ion-channeling viroporin and participates in multiple aspects of the viral life cycle. Its involvement in assembly, budding, and envelope formation is critical for viral morphogenesis . The protein interacts with both other coronavirus proteins and host cell proteins to facilitate these processes. Studies examining recombinant viruses have demonstrated that modifications in viral structural proteins can significantly alter tropism and virulence. Although most research has focused on the S (spike) protein for tropism changes, the E protein's role in pathogenesis is increasingly recognized through its ion channel activity and interactions with the host cell machinery .

What cellular localization patterns does TGEV E protein exhibit?

Immunofluorescence assays performed on both insect and mammalian cells have revealed that the E protein predominantly localizes to membranes . Specific studies on the related IBV coronavirus identified that the C-terminus houses Golgi-targeting information. Researchers have demonstrated that truncation of the C-terminus and production of chimeric E proteins confirm retention at the Golgi complex, while the truncated N-terminus is transported to the cell surface. Further truncation experiments narrowed down the Golgi-targeting motif to a sequence between amino acid residues 44 and 72 .

What expression systems are most effective for studying recombinant TGEV E protein?

Baculovirus expression systems have proven effective for producing recombinant TGEV E protein. Researchers have successfully confirmed the coding potential of the ORF4 (82 amino acids) by expression using a baculovirus vector, yielding a 10K recombinant product that can be recognized by monoclonal antibodies . This system allows for proper protein folding and post-translational modifications. When designing expression constructs, researchers should account for the protein's membrane-associated nature and consider including appropriate tags for purification while ensuring they don't interfere with protein function or structure.

How can researchers effectively detect and analyze TGEV E protein in experimental settings?

Multiple approaches have been validated for E protein detection:

  • Monoclonal antibodies: Five monoclonal antibodies (MAbs) raised against the 10K recombinant product have successfully immunoprecipitated a polypeptide of similar size in TGEV-infected cells .

  • Immunofluorescence assays: These have been effectively performed on both insect and mammalian cells to reveal the membrane association of the protein .

  • Epitope mapping: Two epitopes have been localized within the last 21 C-terminal residues through peptide scanning and analysis of truncated recombinant proteins .

  • Cell surface fluorescence: Anti-E protein MAbs can induce cell surface fluorescence, supporting the Cexo-Nendo orientation model .

What computational methods can improve structural and functional predictions for TGEV E protein?

Several computational approaches have proven valuable:

  • Molecular Dynamics (MD) simulations: These can generate representative conformational ensembles that capture the protein's dynamic properties under physiological conditions .

  • Matrix of Local Coupling Energies (MLCE) method: This integrates analysis of dynamical and energetic properties to identify non-optimized, low-intensity energetic interaction networks on the protein surface. These regions often correspond to antibody recognition sites .

  • Structure-based epitope prediction: This enables the design of diagnostic peptidic probes and can be combined with energy-decomposition approaches to identify potentially immunoreactive regions .

  • Conformational cluster analysis: Analyzing representatives from the most populated conformational clusters (>90% of total conformational ensemble) can reveal functional regions and dynamic properties relevant to protein function .

What role does recombination play in TGEV evolution and how does it impact E protein function?

Recombination is a significant driver of coronavirus evolution and has been documented in natural TGEV isolates. The TGEV Anhui Hefei (AHHF) strain represents a natural recombination between the Purdue and Miller clusters, with two identified breakpoints in the ORF1a gene (nt 4144–9918) and the S gene (nt 21065–23212) . While the reported breakpoints don't directly involve the E protein gene, recombination events can alter the genetic background in which E protein functions, potentially modifying its interactions with other viral proteins. The study of recombinant TGEV strains provides valuable information about coronavirus evolution and molecular pathogenesis .

How can researchers identify and characterize recombination events in TGEV?

Researchers can employ several approaches to identify recombination:

  • Whole-genome sequencing: Complete genomic sequencing of isolates enables comprehensive analysis of potential recombination events .

  • Phylogenetic analysis: Constructing phylogenetic trees based on complete genome sequences can place recombinant strains relative to established viral clusters .

  • Computational recombination analysis: Software tools such as RDP4 can identify potential recombination zones and breakpoints, as demonstrated in the analysis of the TGEV AHHF strain .

  • Identification of parent strains: Analysis can determine major and minor parent strains contributing to recombination events, as seen with SC-Y and H16 as parent strains for the ORF1a recombination in TGEV AHHF .

What experimental approaches can be used to assess the functional consequences of E protein recombination?

To evaluate how recombination affects E protein function:

  • Pathogenicity assessment: Experimental infection of susceptible animals (e.g., piglets for TGEV) can determine whether recombinant viruses maintain or alter virulence. The TGEV AHHF recombinant strain was confirmed to be an enteric pathogenic strain through such testing .

  • Targeted recombination: Laboratory-mediated recombination within viral genes can be promoted through techniques such as passaging helper respiratory virus isolates in cells transfected with defective minigenomes carrying genes from enteric isolates .

  • Analysis of recombinant viruses: Examining tropism changes, viral replication efficiency, and pathological effects can reveal functional consequences of recombination .

  • UTR analysis: Examining the 5' and 3' untranslated regions (UTRs) for deletions or insertions, as well as identifying critical elements like the 'slippery' heptanucleotide sequence and pseudoknot structures, can provide insights into potential changes in viral RNA synthesis mechanisms .

How do mutations in the TGEV E protein affect viroporin activity and viral pathogenesis?

The E protein functions as an ion-channeling viroporin, contributing to several aspects of the viral life cycle . Research approaches to study this activity include:

  • Site-directed mutagenesis: Introducing mutations in the transmembrane domain can disrupt ion channel formation and assess resultant effects on viral replication and pathogenesis.

  • Electrophysiological studies: Measuring ion conductance in artificial membranes or cell systems expressing wild-type versus mutant E proteins can quantify changes in channel activity.

  • Reverse genetics systems: Generating recombinant viruses with modified E proteins allows for direct assessment of viroporin activity's contribution to viral fitness and pathogenicity.

  • Interaction studies: Examining how E protein interacts with host cell components involved in ion homeostasis can reveal mechanisms through which viroporin activity influences pathogenesis .

What structural determinants in TGEV E protein govern its incorporation into virus particles?

The E protein is a minor structural component with approximately 20 molecules incorporated per virion particle . Research approaches to study incorporation include:

  • Deletion and truncation analysis: Creating various E protein mutants can identify regions essential for virion incorporation.

  • Fluorescence microscopy: Tracking the co-localization of E protein with other structural proteins during virion assembly.

  • Immunogold electron microscopy: Visualizing the precise location of E protein within assembled virions.

  • Protein-protein interaction studies: Identifying which viral structural proteins directly interact with E protein during assembly can reveal incorporation mechanisms .

How can functional differences between respiratory and enteric TGEV strains be attributed to E protein variations?

  • Comparative sequence analysis: Identifying amino acid differences in E proteins between respiratory and enteric strains.

  • Chimeric virus construction: Swapping E proteins between strains with different tropisms can reveal their contribution to tissue specificity.

  • Host-protein interaction profiling: Determining whether E proteins from different strains interact with distinct sets of host factors.

  • Analysis of post-translational modifications: Examining whether respiratory and enteric strains modify their E proteins differently in a tissue-specific manner .

How does TGEV E protein compare structurally and functionally with other coronavirus E proteins?

Comparative analysis reveals:

  • Size and topology: Most coronavirus E proteins, including TGEV's, are small (70-110 amino acids) integral membrane proteins with similar predicted membrane topologies .

  • Homology: Sequence comparisons provide strong evidence that other coronaviruses encode polypeptides homologous to TGEV ORF4/E protein .

  • Function: The ion-channeling viroporin activity appears to be conserved across coronavirus E proteins, suggesting evolutionary conservation of this function .

  • Localization: The Golgi-targeting information located in the C-terminus has been identified in both TGEV and IBV E proteins, suggesting a conserved trafficking mechanism .

What methodological approaches can be applied to study coronavirus E protein interactions with the host immune system?

Several approaches can be employed:

  • Epitope mapping: Techniques like peptide scanning have identified immunoreactive regions within the C-terminal domain of TGEV E protein .

  • Structure-based epitope prediction: Computational analyses integrating dynamics and energetic properties can identify potentially immunoreactive regions, as demonstrated with the Matrix of Local Coupling Energies method .

  • Serological testing: Using synthesized linear peptides derived from predicted epitopes as capturing probes in serological assays to detect antibody responses .

  • Immunofluorescence assays: These can determine the accessibility of E protein epitopes on the cell surface, providing insights into protein orientation and potential immune recognition .

How do recombination patterns in TGEV E protein compare to those observed in other coronavirus E proteins?

Comparative recombination analysis reveals:

  • Conservation of recombination mechanisms: The homologous recombination observed in TGEV, involving double crossovers, appears to be a common mechanism across coronaviruses .

  • Breakpoint patterns: While the specific breakpoints identified in TGEV AHHF were in ORF1a and S genes, analysis of additional strains could determine whether the E gene region represents a recombination hotspot or is relatively conserved .

  • Evolutionary implications: Recombination contributes to coronavirus adaptation and host range expansion, with varying impacts on different viral proteins including E protein .

  • Research methodology: The computational analysis approaches using RDP4 software and phylogenetic analysis employed for TGEV can be applied to study recombination patterns in other coronavirus E proteins .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.